Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,2'-methylenebis(1h-indole)
2. Diindolylmethane
1. 1968-05-4
2. Diindolylmethane
3. Di(1h-indol-3-yl)methane
4. 3,3'-methylenebis-1h-indole
5. 3,3'-methylenediindole
6. Dim
7. Arundine
8. 3-(1h-indol-3-ylmethyl)-1h-indole
9. 1h-indole, 3,3'-methylenebis-
10. Di(3-indolyl)methane
11. 3,3'-di-indolylmethane
12. Plant Indole
13. 3,3'-methylenebis(1h-indole)
14. 3,3,-diindolylmethane
15. Mfcd00195766
16. Ssz9hqt61z
17. Bis-1h-indol-3-ylmethane
18. Chebi:50182
19. 3,3'-methanediylbis(1h-indole)
20. Hb 236
21. 3,3 Inverted Exclamation Marka-diindolylmethane
22. 3-diindolyl Methane
23. 3,3'-diindolymethane
24. Diidolylmethane
25. Infemin
26. Ccris 5806
27. 33diindolylmethyle
28. Di-3-indolylmethane
29. Nsc708486
30. 3-3-diindolylmethane
31. 33'-diindolylmethane
32. Spectrum2_001711
33. Spectrum3_001989
34. Spectrum5_001955
35. Unii-ssz9hqt61z
36. Cbiol_001839
37. Oprea1_472633
38. Oprea1_740951
39. Bspbio_001290
40. Bspbio_003589
41. Cbdive_010856
42. Kbiogr_000010
43. Kbioss_000010
44. Mls006011847
45. Schembl325162
46. Spectrum1505331
47. Spbio_001722
48. 3,3'-di(indol-3-yl)methane
49. Bml3-f11
50. Chembl446452
51. 3,3'-diindolylmethane (dim)
52. Diindolylmethane [vandf]
53. Dtxsid8037047
54. Gtpl11208
55. Kbio2_000010
56. Kbio2_002578
57. Kbio2_005146
58. Kbio3_000019
59. Kbio3_000020
60. Kbio3_003002
61. Bio1_000125
62. Bio1_000614
63. Bio1_001103
64. Bio2_000010
65. Bio2_000490
66. Diindolylmethane, 3,3'-
67. Hms1361a12
68. Hms1791a12
69. Hms1989a12
70. Hms3402a12
71. Zinc187911
72. 3,3'-diindolylmethane, Aldrichcpr
73. Act06989
74. Albb-016048
75. Bcp00470
76. Ccg-39861
77. Gr-207
78. Hsci1_000069
79. S4728
80. Stk263696
81. Akos003627372
82. Am84671
83. Cs-1652
84. Db11875
85. Ks-5266
86. Nsc-708486
87. Sb16901
88. Idi1_033760
89. 3,3'-diindolylmethane [who-dd]
90. Ncgc00095348-01
91. Ncgc00095348-02
92. Ncgc00095348-03
93. Ncgc00095348-04
94. Ncgc00095348-05
95. Ncgc00095348-06
96. Ncgc00095348-07
97. Ac-11611
98. Hy-15758
99. Nci60_038418
100. Smr001828114
101. Sy038972
102. 3,3'-diindolylmethane, >=98% (hplc)
103. 3,3'-diindolylmethane, Analytical Standard
104. Db-011102
105. Ft-0614061
106. M1399
107. A16321
108. D-3720
109. 968d054
110. Q4634053
111. Brd-k37846922-001-05-2
112. Brd-k37846922-001-06-0
113. Brd-k37846922-001-09-4
114. C444299000
| Molecular Weight | 246.31 g/mol |
|---|---|
| Molecular Formula | C17H14N2 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 2 |
| Exact Mass | 246.115698455 g/mol |
| Monoisotopic Mass | 246.115698455 g/mol |
| Topological Polar Surface Area | 31.6 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 286 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Diindolylmethane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diindolylmethane, including repackagers and relabelers. The FDA regulates Diindolylmethane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diindolylmethane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diindolylmethane supplier is an individual or a company that provides Diindolylmethane active pharmaceutical ingredient (API) or Diindolylmethane finished formulations upon request. The Diindolylmethane suppliers may include Diindolylmethane API manufacturers, exporters, distributors and traders.
click here to find a list of Diindolylmethane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diindolylmethane DMF (Drug Master File) is a document detailing the whole manufacturing process of Diindolylmethane active pharmaceutical ingredient (API) in detail. Different forms of Diindolylmethane DMFs exist exist since differing nations have different regulations, such as Diindolylmethane USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diindolylmethane DMF submitted to regulatory agencies in the US is known as a USDMF. Diindolylmethane USDMF includes data on Diindolylmethane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diindolylmethane USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diindolylmethane suppliers with USDMF on PharmaCompass.
Diindolylmethane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diindolylmethane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diindolylmethane GMP manufacturer or Diindolylmethane GMP API supplier for your needs.
A Diindolylmethane CoA (Certificate of Analysis) is a formal document that attests to Diindolylmethane's compliance with Diindolylmethane specifications and serves as a tool for batch-level quality control.
Diindolylmethane CoA mostly includes findings from lab analyses of a specific batch. For each Diindolylmethane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diindolylmethane may be tested according to a variety of international standards, such as European Pharmacopoeia (Diindolylmethane EP), Diindolylmethane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diindolylmethane USP).
LOOKING FOR A SUPPLIER?
